Optimal models to evaluate the protective efficacy of tuberculosis vaccines.
about
Immunoglobulin G1 enzyme-linked immunosorbent assay for diagnosis of Johne's Disease in red deer (Cervus elaphus).Protection Induced by Simultaneous Subcutaneous and Endobronchial Vaccination with BCG/BCG and BCG/Adenovirus Expressing Antigen 85A against Mycobacterium bovis in CattleEvolution of M. bovis BCG Vaccine: Is Niacin Production Still a Valid Biomarker?Mycobacterium bovis BCG substrains confer different levels of protection against Mycobacterium tuberculosis infection in a BALB/c model of progressive pulmonary tuberculosis.The epidemiology of Mycobacterium bovis in wild deer and feral pigs and their roles in the establishment and spread of bovine tuberculosis in New Zealand wildlife.Farmed deer: A veterinary model for chronic mycobacterial diseases that is accessible, appropriate and cost-effective.Immunological and molecular characterization of susceptibility in relationship to bacterial strain differences in Mycobacterium avium subsp. paratuberculosis infection in the red deer (Cervus elaphus).Evolution and Strain Variation in BCG.Use of the Human Vaccine, Bacillus Calmette Guérin in Deer
P2860
Q24535037-2CDD6B23-141E-49AA-BFF6-8A3482CB5F90Q27346370-02E9F3C0-2438-40F4-8811-510DEDCD3E13Q28083050-AB1F4D68-704D-4638-8AD8-98508F5A535EQ34491796-65C05FEA-3357-4E46-885E-6E6EDAB36DA0Q35312271-821AD448-68F4-4C68-8A19-DF39B6EDCFD3Q38181465-E6694F73-1717-42BA-8E94-74EEECCFD727Q42243776-E84263AB-EC9C-406E-A571-A08F96F9E884Q47223264-6BC9B05D-67A7-439C-811A-1A92136281F6Q57817663-E738B4C2-7D70-4405-B78C-BD037ABD15C7
P2860
Optimal models to evaluate the protective efficacy of tuberculosis vaccines.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Optimal models to evaluate the protective efficacy of tuberculosis vaccines.
@ast
Optimal models to evaluate the protective efficacy of tuberculosis vaccines.
@en
Optimal models to evaluate the protective efficacy of tuberculosis vaccines.
@nl
type
label
Optimal models to evaluate the protective efficacy of tuberculosis vaccines.
@ast
Optimal models to evaluate the protective efficacy of tuberculosis vaccines.
@en
Optimal models to evaluate the protective efficacy of tuberculosis vaccines.
@nl
prefLabel
Optimal models to evaluate the protective efficacy of tuberculosis vaccines.
@ast
Optimal models to evaluate the protective efficacy of tuberculosis vaccines.
@en
Optimal models to evaluate the protective efficacy of tuberculosis vaccines.
@nl
P2093
P356
P1433
P1476
Optimal models to evaluate the protective efficacy of tuberculosis vaccines.
@en
P2093
Griffin JF
Mackintosh CG
Rodgers CR
P304
P356
10.1054/TUBE.2000.0271
P577
2001-01-01T00:00:00Z